1. Home
  2. FGEN vs MOBX Comparison

FGEN vs MOBX Comparison

Compare FGEN & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • MOBX
  • Stock Information
  • Founded
  • FGEN 1993
  • MOBX 2020
  • Country
  • FGEN United States
  • MOBX United States
  • Employees
  • FGEN N/A
  • MOBX N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • MOBX
  • Sector
  • FGEN Health Care
  • MOBX
  • Exchange
  • FGEN Nasdaq
  • MOBX Nasdaq
  • Market Cap
  • FGEN 34.5M
  • MOBX 29.9M
  • IPO Year
  • FGEN 2014
  • MOBX N/A
  • Fundamental
  • Price
  • FGEN $0.36
  • MOBX $2.05
  • Analyst Decision
  • FGEN
  • MOBX
  • Analyst Count
  • FGEN 0
  • MOBX 0
  • Target Price
  • FGEN N/A
  • MOBX N/A
  • AVG Volume (30 Days)
  • FGEN 911.8K
  • MOBX 2.0M
  • Earning Date
  • FGEN 11-12-2024
  • MOBX 02-18-2025
  • Dividend Yield
  • FGEN N/A
  • MOBX N/A
  • EPS Growth
  • FGEN N/A
  • MOBX N/A
  • EPS
  • FGEN N/A
  • MOBX N/A
  • Revenue
  • FGEN $180,015,000.00
  • MOBX $3,921,000.00
  • Revenue This Year
  • FGEN $19.67
  • MOBX N/A
  • Revenue Next Year
  • FGEN N/A
  • MOBX N/A
  • P/E Ratio
  • FGEN N/A
  • MOBX N/A
  • Revenue Growth
  • FGEN 16.15
  • MOBX 214.69
  • 52 Week Low
  • FGEN $0.18
  • MOBX $0.55
  • 52 Week High
  • FGEN $2.93
  • MOBX $12.47
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 45.24
  • MOBX 76.17
  • Support Level
  • FGEN $0.31
  • MOBX $0.96
  • Resistance Level
  • FGEN $0.37
  • MOBX $1.30
  • Average True Range (ATR)
  • FGEN 0.03
  • MOBX 0.35
  • MACD
  • FGEN -0.01
  • MOBX 0.10
  • Stochastic Oscillator
  • FGEN 25.66
  • MOBX 88.90

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About MOBX Mobix Labs Inc.

Mobix Labs Inc is a fabless semiconductor company developing disruptive next generation wireless and connected solutions that are designed to cater to a broad range of applications in markets including 5G infrastructure, satellite communications, automotive, consumer electronics, e-mobility, healthcare, infrastructure and defense.

Share on Social Networks: